AstraZeneca snaps up Fusion Pharmaceuticals Inc for over $2 billion
Tuesday, 19 March 2024, 9:50 am
Another week, another takeover deal from AstraZeneca.
Last week AstraZeneca bought Amolyt Pharma for over $1 billion and today the FTSE 100-listed giant is paying over $2 billion for Fusion Pharmaceutical, a US-listed biopharmaceutical company...